ArticleJournal of surgical case reports2025
Sellar-suprasellar pituitary lymphoma mimicking pituitary adenoma: a case report with literature review.
Article in Journal of surgical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pituitary T-lymphoblastic lymphoma combined with pituitary adenoma: a rare case report.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sellar-suprasellar lymphoma (SSL) is an extremely rare tumor, constituting fewer than 1%. It is a variant of primary central nervous system lymphoma. SSL is usually seen in people around 60 years of age, exhibiting a slight female predominance. Diffuse large B-cell lymphoma represents the most predominant subtype. We report a 57-year-old female with a 9-month history of worsening severe left-sided headaches involving the left eye, associated with nausea, vomiting, blurred vision, and significant unintentional weight loss. Initial imaging revealed a pituitary tumor, and she was diagnosed with a pituitary macroadenoma. She underwent endoscopic trans-sphenoidal debulking. Histopathological examination confirmed a high-grade diffuse large B-cell lymphoma. She was treated with chemotherapy and radiotherapy which reduced the mass and improved her symptoms. Our case underscores the importance of considering SSL, particularly in patients with unusual sellar masses. Effective treatment needs a multidisciplinary approach, integrating radiotherapy and endocrine support when demanded.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.